Apeloa Pharmaceutical News and Activities
Presence
Apeloa Pharmaceutical develops, manufactures, and sells pharmaceutical products and health ingredients. Its main offerings include active pharmaceutical ingredients, finished medicines, and specialty chemicals for drug companies, healthcare providers, and industrial customers.
Apeloa Pharmaceutical products and services overview:
- Active ingredients
- Finished medicines
- Health ingredients
- Specialty chemicals
- Contract manufacturing
Revenue: ~$1 billion
Employees: 7,000
Headquarters: Dongyang, China
Apeloa Pharmaceutical is one of the...
Apeloa Pharmaceutical is a company listed under the stock ticker 000739 (CN).
Executives
View the org chart displaying its 10 main executives
Most searched biographies at Apeloa Pharmaceutical
- Xinliang Xu, Chief Executive Officer and Vice Chairman of the Board
- Fangmeng Zhu, Chairman of the Board
- Cai Lei, Chief Executive Officer of Apeloa Pharma Solutions
Create your alert
to follow the executive moves at Apeloa Pharmaceutical.
Pharmaceuticals
Apeloa Pharmaceutical has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).
Popular M&A news in Pharmaceuticals
- Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
- Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
- Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).
Popular contacts in Pharmaceuticals
News
Press releases by Apeloa Pharmaceutical
Social media about Apeloa Pharmaceutical
- Apeloa Pharmaceutical on Wikipedia, Google News & Yahoo Finance
- Apeloa Pharmaceutical on LinkedIn, X (Twitter) & YouTube
